2026 Lorlatinib/lorlatinib sales price reference in China

Lorlatinib/Lorlatinib (Lorlatinib) is a highly effective targeted therapy drug, mainly used to treat ALK-positive non-small cell lung cancer (NSCLC). Since the drug entered the Chinese market, its price has been a focus of concern among patients. Although the therapeutic effect of lorlatinib has been widely recognized, its higher price has made many patients worried about the cost of long-term treatment.

In the Chinese market, the original drug name of lorlatinib is "lorlatinib tablets", which has been included in the Class B medical insurance reimbursement directory. Common specifications are 90 tablets of 25mg and 30 tablets of 100mg. The price per box is about 20,000 yuan. This price may still be high for many patients, especially those who require long-term medication. Therefore, patients in some areas with poor economic conditions may face certain financial pressure. However, the medical insurance reimbursement policy provides certain subsidies to eligible patients, reducing the burden of out-of-pocket expenses.

In addition to domestic original drugs, the Hong Kong original version of lorlatinib is usually more expensive, with a reference price of between 30,000 and 50,000 yuan. Due to the high cost of importing and distributing drugs in Hong Kong, this price is relatively expensive, but its efficacy and quality are still widely recognized by patients. For some patients who wish to purchase it through formal channels, the Hong Kong version of lorlatinib is still an option.

In addition, there are also some generic drugs on the market, which are cheaper than the original drugs and are suitable for patients with more difficult economic conditions. Taking the 100mg*30 tablets produced by a Lao pharmaceutical factory as an example, the price is about 1,000 yuan (exchange rate fluctuations may cause the price to change). Although the price of generic drugs is much lower than that of the original drugs, their ingredients are basically the same as the original drugs, so the therapeutic effects on patients are also similar. However, when patients choose generic drugs, they need to pay special attention to the quality of the drugs and formal channels to ensure the safety of the drugs.

Keyword tags: Lorlatinib, Lorlatinib, sales price, non-small cell lung cancer, price reference, original drug, generic drug, drug pricing

References:https://www.ema.europa.eu/en/documents/product-information/lorviqua-epar-product-information_en.pdf